Indication
Normal Liver Function
1 clinical trial
1 product
Clinical trial
An Open-label, Single-dose, Phase I Study to Assess the Pharmacokinetics and Safety of JT001 in Subjects With Mild and Moderate Hepatic Impairment Compared to Subjects With Normal Hepatic FunctionStatus: Completed, Estimated PCD: 2023-08-18
Product
Deuremidevir Hydrobromide